We are live on
!
Find out more
EEG
E.E. Geduld Portfolio holdings
AUM
$178M
1-Year Est. Return
29.34%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.34%
3 Year Est. Return
+59.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$161M
AUM Growth
+$11M
(+7.3%)
Cap. Flow
-$5.71M
Cap. Flow
% of AUM
-3.55%
Top 10 Holdings %
Top 10 Hldgs %
44.28%
Holding
361
New
80
Increased
31
Reduced
55
Closed
58
Avg Time Held Equity + Options
3.6
quarters
Top 10 Avg Time Held Equity + Options
2.1
quarters
Top 20 Avg Time Held Equity + Options
2.3
quarters
Avg Time Held Equity only
3.9
quarters
Top 10 Avg Time Held Equity only
3.5
quarters
Top 20 Avg Time Held Equity only
3.3
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Capri Holdings
CPRI
|
+$1.13M |
| 2 |
Biogen
BIIB
|
+$803K |
| 3 |
AbbVie
ABBV
|
+$773K |
| 4 |
MGM Resorts International
MGM
|
+$610K |
| 5 |
Kearny Financial
KRNY
|
+$521K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$1.79M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
+$1.34M |
| 3 |
General Motors Company
GM.WS.B
|
+$1.2M |
| 4 |
CELG
Celgene Corp
CELG
|
+$857K |
| 5 |
Taro Pharmaceutical Industries Ltd.
TARO
|
+$856K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 33.05% |
| 2 | Miscellaneous | 33% |
| 3 | Healthcare | 14.28% |
| 4 | Consumer Discretionary | 7.06% |
| 5 | Technology | 5.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
26
Capri Holdings
CPRI
$1.72B
| $842K | 0.52% |
+20,000
| New | +$1.13M |
2015 Q2
0 quarters
|
|
27
Par Pacific Holdings
PARR
$4.16B
| $842K | 0.52% |
45,000
-25,982
| -37% | -$600K |
2014 Q3
3 quarters
|
|
28
PUT
Rio Tinto
RIO
$153B
| $824K | 0.51% |
+20,000
| New | +$878K |
2015 Q2
0 quarters
|
|
|
29
Biogen
BIIB
$33.9B
| $808K | 0.5% |
+2,000
| New | +$803K |
2015 Q2
0 quarters
|
|
30
DELISTED
Sage Therapeutics
SAGE
| $803K | 0.5% |
11,000
+1,000
| +10% | +$64.3K |
2015 Q1
1 quarter
|
|
|
31
AbbVie
ABBV
$497B
| $796K | 0.5% |
+11,846
| New | +$773K |
2015 Q2
0 quarters
|
|
32
Halozyme
HALO
$12.6B
| $791K | 0.49% |
35,050
| – | – |
2013 Q2
8 quarters
|
|
|
CY
33
DELISTED
Cypress Semiconductor
CY
| $764K | 0.48% |
65,000
+15,000
| +30% | +$198K |
2015 Q1
1 quarter
|
|
34
Tootsie Roll Industries
TR
$2.83B
| $749K | 0.47% |
32,080
| – | – |
2014 Q4
2 quarters
|
|
|
WIFI
35
DELISTED
Boingo Wireless, Inc.
WIFI
| $738K | 0.46% |
89,400
+4,400
| +5% | +$37.9K |
2013 Q3
7 quarters
|
|
36
Precigen
PGEN
$2.74B
| $734K | 0.46% |
15,179
+4,670
| +44% | +$197K |
2014 Q4
2 quarters
|
|
|
TWTR
37
CALL
DELISTED
Twitter, Inc.
TWTR
| $724K | 0.45% |
+20,000
| New | +$817K |
2015 Q2
0 quarters
|
|
38
Boston Scientific
BSX
$63.5B
| $710K | 0.44% |
40,110
+110
| +0.3% | +$1.97K |
2013 Q2
8 quarters
|
|
|
SFLY
39
DELISTED
Shutterfly, Inc.
SFLY
| $669K | 0.42% |
14,000
+4,000
| +40% | +$186K |
2015 Q1
1 quarter
|
|
40
Ciena
CIEN
$57.4B
| $651K | 0.4% |
27,500
-27,500
| -50% | -$628K |
2014 Q4
2 quarters
|
|
41
CALL
DELISTED
Coterra Energy
CTRA
| $631K | 0.39% |
20,000
| – | – |
2015 Q1
1 quarter
|
|
42
DELISTED
Bank Of America Corporation Ws A
BAC.WS.A
| $617K | 0.38% |
100,000
| – | – |
2013 Q2
8 quarters
|
|
43
Blackstone
BX
$86.2B
| $613K | 0.38% |
15,285
| – | – |
2013 Q2
8 quarters
|
|
44
DELISTED
Esperion Therapeutics
ESPR
| $613K | 0.38% |
7,500
+2,500
| +50% | +$245K |
2014 Q4
2 quarters
|
|
|
WWAV
45
DELISTED
The WhiteWave Foods Company
WWAV
| $611K | 0.38% |
12,500
-2,500
| -17% | -$117K |
2014 Q2
4 quarters
|
|
46
CALL
Teva Pharmaceutical Industries Limited
TEVA
$48B
| $591K | 0.37% |
10,000
-15,000
| -60% | -$925K |
2015 Q1
1 quarter
|
|
47
Zoetis
ZTS
$31.3B
| $579K | 0.36% |
12,000
| – | – |
2013 Q4
6 quarters
|
|
48
DELISTED
Infinera Corporation Common Stock
INFN
| $577K | 0.36% |
27,500
+2,500
| +10% | +$50.8K |
2015 Q1
1 quarter
|
|
49
CALL
Himax Technologies
HIMX
$2.23B
| $562K | 0.35% |
+70,000
| New | +$476K |
2015 Q2
0 quarters
|
|
|
SGEN
50
DELISTED
Seagen Inc. Common Stock
SGEN
| $561K | 0.35% |
11,600
+1,600
| +16% | +$66K |
2013 Q2
8 quarters
|
|
Similar funds
BC
PFM
SRP
CF
SA
WSA
SIG
VWM
E.E. Geduld's Q2 2015 Portfolio in Review
As of Q2 2015, E.E. Geduld held 361 positions worth $161M, up 7.3% from $150M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
E.E. Geduld withdrew a net $5.71M in Q2 2015, closing 58 positions and reducing 55 holdings. Its most notable exit was PHARMACYCLICS INC, an estimated $1.79M position sold in full.
By sector, the portfolio is most concentrated in Financials at 33% of assets, down from 33% a quarter earlier, followed by Miscellaneous and Healthcare.
Against the trend, E.E. Geduld opened a new position in Capri Holdings worth $842K.
- E.E. Geduld's largest Q2 2015 buy was Capri Holdings: 20,000 shares worth $842K.
- E.E. Geduld added most to Blackstone Mortgage Trust in Q2 2015, an estimated $355K increase.
- E.E. Geduld's biggest Q2 2015 reduction was Alnylam Pharmaceuticals, cutting an estimated $1.34M.
- E.E. Geduld fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $1.79M.
- E.E. Geduld's ten largest holdings make up 44% of its $161M portfolio in Q2 2015.
- E.E. Geduld opened 80 new positions and closed 58 in Q2 2015.
- E.E. Geduld's portfolio value rose 7.3% quarter-over-quarter to $161M.
Based on E.E. Geduld's 13F filing for Q2 2015, filed 7 Aug 2015.